Synchrony Financial (SYF) EPS Estimated At $0.60

Beese Fulmer Investment Management Inc. now owns 75,860 shares of the financial services provider's stock valued at $2,262,000 after buying an additional 571 shares during the last quarter.

A number of other hedge funds have also bought and sold shares of the stock. Creative Planning increased its position in shares of Synchrony Financial by 4.3% in the first quarter. Beese Fulmer Investment Management Inc. increased its position in Synchrony Financial by 0.8% in the second quarter. Looking back over the last month, shares have performed 0.31%. Edwards & Company Inc. raised its stake in shares of Synchrony Financial by 41.7% in the first quarter. Gulf International Bank UK Ltd now owns 253,645 shares of the financial services provider's stock valued at $8,700,000 after buying an additional 3,100 shares during the period.

Synchrony Financial (SYF) traded up 0.61% on Wednesday, hitting $29.51. Creative Planning now owns 5,863 shares of the financial services provider's stock worth $201,000 after buying an additional 240 shares during the last quarter. Kentucky Retirement Systems Insurance Trust Fund purchased a new position in Synchrony Financial during the fourth quarter valued at $921,000. Raymond James Trust N.A. now owns 6,625 shares of the financial services provider's stock valued at $227,000 after buying an additional 274 shares during the period. Institutional investors own 88.04% of the company's stock. The stock of Synchrony Financial (NYSE:SYF) has "Buy" rating given on Tuesday, August 18 by Zacks.

Investors who are keeping close eye on Synchrony Financial (SYF) stock; watched recent volatility movements, they can see that shares have been recorded at 1.69% for the week, and 1.85% for the last month. Quadrature Capital Ltd now owns 44,242 shares of the financial services provider's stock valued at $1,605,000 after buying an additional 11,349 shares during the period. Synchrony Financial (NYSE:SYF) shares have been recently spotted -22.32% away from the 52-week high, and 13.65% away from the 52-week low mark. After $0.61 actual EPS reported by Synchrony Financial for the previous quarter, Wall Street now forecasts -1.64 % negative EPS growth. The company had revenue of $3.59 billion during the quarter, compared to the consensus estimate of $3.54 billion. During the same quarter in the prior year, the business earned $0.70 earnings per share. On average, analysts predict that Synchrony Financial will post $2.58 EPS for the current fiscal year. This repurchase authorization permits the financial services provider to repurchase up to 7.6% of its stock through open market purchases. Shares repurchase programs are typically a sign that the company's leadership believes its shares are undervalued.

TRADEMARK VIOLATION WARNING: "Armstrong Shaw Associates Inc". If you are viewing this article on another publication, it was copied illegally and republished in violation of United States and global copyright legislation. Verona Pharma PLC had 19 analyst reports since September 18, 2015 according to SRatingsIntel. Jefferies Group LLC decreased their target price on shares of Synchrony Financial from $45.00 to $40.00 and set a "buy" rating for the company in a research report on Monday, May 1st. BTIG Research dropped their price target on shares of Synchrony Financial from $42.00 to $36.00 and set a "buy" rating on the stock in a research note on Monday, May 1st.

SYF has been the subject of several research reports. Oppenheimer Holdings, Inc. began coverage on shares of Synchrony Financial in a research note on Tuesday, April 11th. They set a "market perform" rating on the stock. ValuEngine lowered Synchrony Financial from a "buy" rating to a "hold" rating in a research report on Friday, June 2nd. A rating of less than 2 means buy, "hold" within the 3 range, "sell" within the 4 range, and "strong sell" within the 5 range. The company now has a consensus rating of "Buy" and a consensus price target of $37.58. The shares were purchased at an average cost of $27.80 per share, for a total transaction of $500,400.00. Following the transaction, the director now directly owns 55,389 shares of the company's stock, valued at $1,539,814.20. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. More interesting news about Synchrony Financial (NYSE:SYF) was released by: Nasdaq.com and their article: "Synchrony Financial (SYF) Q2 Earnings: What's in the Cards?" with publication date: July 19, 2017.